Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study.

@article{Delanaye2013CholecalciferolIH,
  title={Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study.},
  author={Pierre Delanaye and Laurent Weekers and Xavier Warling and Martial Moonen and Nicole Smelten and Laurent M{\'e}dart and J M Krzesinski and Etienne Cavalier},
  journal={Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association},
  year={2013},
  volume={28 7},
  pages={
          1779-86
        }
}
BACKGROUND The role of cholecalciferol supplementation in end-stage renal disease (ESRD) patients has been questioned. The objective of this randomized double-blinded study is to assess whether cholecalciferol therapy can increase serum 25-hydroxyvitamin D [25(OH)D] levels in haemodialysed patients and the safety implications of this therapy on certain biological parameters and vascular calcifications score. METHODS Forty-three haemodialysis patients were randomized to receive placebo or… CONTINUE READING
21 Citations
43 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 21 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 43 references

Similar Papers

Loading similar papers…